Monday, June 15, 2020

Cancer: Drug with new approach on impeding DNA repair shows promise in first clinical trial

Berzosertib, an ATR-targeting drug, improves progression-free survival in combination with chemotherapy in patients with high-grade serous ovarian cancer.

from Latest Science News -- ScienceDaily https://ift.tt/3hpjKKi
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Scientists found the “holy grail” gene that could one day help humans regrow limbs

Scientists studying axolotls, zebrafish, and mice have uncovered a shared set of genes that may one day help humans regrow lost limbs. By id...